Tele-Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis: Results of a Randomized Controlled TrialARTHRITIS CARE & RESEARCHIF3.32018-01-23132OAAI
Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease ActivitySCANDINAVIAN JOURNAL OF IMMUNOLOGYIF1.62017-11-0126OAAI
MAGNETIC RESONANCE IMAGING JOINT SPACE NARROWING IS AN INDEPENDENT PREDICTOR OF RADIOGRAPHIC AND MRI DAMAGE PROGRESSION IN PATIENTS WITH EARLY RHEUMATOID ARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.62016-06-010PREAI
THE TIME WINDOW TO DETERMINE TROUGH VALUES OF ETANERCEPT IS IMPORTANT IN PERSONALIZED MEDICINE REGIME INDEPENDENTLY OF METHOTREXATE COADMINISTRATIONANNALS OF THE RHEUMATIC DISEASESIF20.62016-06-010PREAI
Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registryANNALS OF THE RHEUMATIC DISEASESIF20.62015-12-0160PREAI
RISK OF SERIOUS ADVERSE EFFECTS ASSOCIATED WITH DIFFERENT BIOLOGICAL AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED TRIALSANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-014PREAI
RHEUMATOID ARTHRITIS AND MORTALITY FOLLOWING HOSPITALIZED PNEUMONIA; A POPULATION-BASED COHORT STUDY WITH DIAGNOSIS VALIDATIONANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-010PREAI
TUMOUR NECROSIS FACTOR ALPHA INHIBITOR TREATMENT NORMALISES HAND BONE LOSS IN A MINORITY OF RHEUMATOID ARTHRITIS PATIENTS TREATED IN CLINICAL PRACTICE. RESULTS FROM THE COPENHAGEN OSTEOARTHRITIS STUDY AND THE DANBIO REGISTRYANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-010PREAI
EFFECT OF METHOTREXATE AND INTRA-ARTICULAR BETAMETHASONE WITH OR WITHOUT ADDITIONAL CYCLOSPORINE ON MAGNETIC RESONANCE IMAGING (MRI)-DETERMINED INFLAMMATORY AND DESTRUCTIVE CHANGES IN VERY EARLY RHEUMATOID ARTHRITIS RESULTS FROM A 24-MONTHS' RANDOMISED DOUBLE BLIND PLACEBO CONTROLLED TRIALANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-011PREAI
Which Factors Influence Radiographic Progression During Treatment with Tumor Necrosis Factor Inhibitors in Clinical Practice? Results from 930 Patients with Rheumatoid Arthritis in the Nationwide Danish DANBIO RegistryJOURNAL OF RHEUMATOLOGYIF3.42014-10-0112OAAI
Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trialANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-0132PREAI
EFFECTIVENESS OF REPEATED COURSES OF RITUXIMAB IN RA - RESULTS FROM THE CERERRA COLLABORATIONANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-010PREAI
FIXED VERSUS ON-FLARE RETREATMENT WITH RITUXIMAB IN RA - RESULTS FROM THE CERERRA COLLABORATIONANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-010PREAI
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registryANNALS OF THE RHEUMATIC DISEASESIF20.62013-07-01126PREAI
Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registryANNALS OF THE RHEUMATIC DISEASESIF20.62013-01-0128PREAI
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO RegistryANNALS OF THE RHEUMATIC DISEASESIF20.62013-01-01145OAAI
CLINICAL RESPONSE, DRUG SURVIVAL AND PREDICTORS THEREOF IN 432 PATIENTS WITH ANKYLOSING SPONDYLITIS SWITCHING ANTI TUMOR NECROSIS FACTOR α THERAPY: RESULTS FROM THE DANISH NATIONWIDE DANBIO REGISTRYANNALS OF THE RHEUMATIC DISEASESIF20.62012-06-010PREAI
SEROPOSITIVITY AND RESPONSE TO RTX: DATA FROM THE CERERRA COLLABORATIONANNALS OF THE RHEUMATIC DISEASESIF20.62012-06-011PREAI
Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRPANNALS OF THE RHEUMATIC DISEASESIF20.62012-06-0177PREAI
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaborationANNALS OF THE RHEUMATIC DISEASESIF20.62012-03-0167PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向